Great expectations from a different approach to the treatment of acute myocardial infarction : cytoprotection
Author:
- 1 April 1999
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 69 (1) , 15-18
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Recombinant growth hormone: A new cardiovascular drug therapyAmerican Heart Journal, 1996
- Mechanisms of immune-mediated myocyte injury.Circulation, 1994
- Role of transforming growth factor ß in cardioprotection of the ischemic-reperfused myocardium1993
- Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence.Journal of Clinical Investigation, 1992
- Salvage of Infarcted Myocardium by Angiogenic Action of Basic Fibroblast Growth FactorScience, 1992
- Preservation of the myocardial collagen framework by human growth hormone in experimental infarctions and reduction in the incidence of ventricular aneurysmsInternational Journal of Cardiology, 1992
- Reversible Dilated Cardiomyopathy Due to Growth Hormone DeficiencyAmerican Journal of Clinical Pathology, 1992
- Bivalent effects of human growth hormone in experimental myocardial infarcts. Protective when administered alone and aggravating when combined with beta blockers.Japanese Heart Journal, 1990
- Collateral Circulation1971
- Hormonal Control of Collateral CirculationCirculation Research, 1966